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1 Background
Biomarkers and clinical predictors are sought to assist in disease screening, in diagnosis and in
making prognostic assessments for patients after diagnosis. This is an active area of research
that has met with mixed success. In cancer research in particular, many biomarkers have been
discovered but none, on its own, has yet been shown to have adequate performance for use in
clinical practice. Efforts are currently underway to assemble panels of markers with the goal of
developing marker combinations that have better performance.
We have previously investigated statistical characteristics of a single biomarker that lead to
accurate classification or prediction of outcomes for individuals (Pepe et al., 2004). We and others
have shown that the marker must be very strongly associated with outcome, having an odds ratio
much larger than is typically observed in epidemiologic studies of association. This observation
has been useful in setting targets and expectations for the performance of single biomarkers. In this
paper, we turn our attention to the setting where the performance of the best-performing marker is
still inadequate, and we seek to combine other markers with it. We ask what statistical characteris-
tics of an additional marker lead to substantially improved performance. This might help develop
strategies for assembling panels of markers for evaluation in rigorous validation studies.
As an example we consider CA-125, which is a biomarker for ovarian cancer. For early detec-
tion of ovarian cancer, CA-125 was recently shown to have the best performance among a panel of
6 markers studied (Anderson et al., 2010). Yet its performance is far from adequate for population
screening. The area under the receiver operating characteristic (ROC) curve (AUC) is approxi-
mately 0.7 for detecting ovarian cancer 2 years prior to symptomatic clinical diagnosis. Moreover,
using a threshold that sets the false positive rate (FPR) at 0.05, approximately 18% of cancers
can be detected early with CA-125, i.e. the true positive rate (TPR) is only 0.18. Can we expect
that combining other markers with CA-125 will improve performance substantially for screening?
How should we identify markers for combining with CA-125?
A common intuitively appealing strategy for selecting novel markers to combine with each
other and with existing markers is to identify those with good performance on their own. One
1
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may prioritize those with low correlation since they apparently provide independent information.
Moreover, in practice linear marker combinations are often studied. For example, Gail (2008)
examined the potential improvement of the performance of standard clinical factors for predicting
breast cancer that could be gained by adding seven SNPs with good performance on their own,
assuming statistical independence with standard risk factors and using a linear logistic model for
combination. He found that the area under the ROC curve increased only slightly from 0.607 to
0.632. As another example, Anderson et al. (2010) recently studied a panel of 6 ovarian cancer
markers. Markers were selected for inclusion in this panel if they had high ranking performance
on their own and combinations were studied primarily using linear algorithms.
In the first part of this paper we quantify the potential gain in classification performance that can
be achieved by combining markers assuming various classic statistical and biologically motivated
models for their joint distributions. We also note the function for combining them optimally and
compare with the linear combination function. Practical implications of our results are discussed in
the second part of this paper. In particular, we show that a broader approach to selecting panels of
markers than the current popular approach may lead to better marker combinations but will require
large sample sizes in order to be fruitful.
2 Marker Distributions and Combinations
2.1 Methods
We study marker combinations for classifying subjects according to true outcome status D, with
D = 1 denoting a case and D = 0 a control. We use a variety of statistical models for the joint
distributions of markers and quantify what can possibly be achieved by combining them. Our
calculations are done for the models themselves, not for estimates based on a sample of data. Sam-
pling variability in real data adds another layer of complexity that we address later. For simplicity
and to gain insights we focus on combining two markers. One of the markers, that we call the
standard or baseline markerX , has specified performance on its own. We consider another marker
that we call the novel marker Y , vary the performance of Y relative to X , and determine to what
2
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extent the performance of the combination (X, Y ) is improved relative toX alone. The sensitivity
(TPR) and specificity (1-FPR) and the ROC curve, which is a plot of TPR versus FPR, are used to
quantify classification performance.
Long established statistical theory (McIntosh and Pepe, 2002; Neyman and Pearson, 1933) has
shown that the optimal combination of (X, Y ) is obtained by calculating the risk score function of
X and Y , defined as r(X, Y ) = P (D = 1|X, Y ), and setting criteria for positivity as
r(X, Y ) > threshold.
In other words, the ROC curve for r(X, Y ) is higher and further to the left than the ROC curve
for any other combination of (X, Y ). Therefore, we calculate the optimal combination function,
r(X, Y ), for each model and compare ROC values for r(X, Y ) with corresponding ROC values
forX in order to quantify the improvement in performance gained by combining Y withX .
2.2 Results
2.2.1 Bivariate Binormal Equal Correlation Markers
The bivariate binormal model is a classic statistical model for two diagnostic tests or markers (Metz
and Kronman, 1980). It assumes that the markers, (X, Y ), have a bivariate normal distribution in
cases and controls. Although we focus on normal models, note that the results apply much more
generally to markers that are normal after some unspecified monotone transformations, since the
ROC curve is unchanged by such transformations of the data (Pepe, 2003). We further assume here
that case and control distributions have the same covariance matrix. Without losing generality, in
controls the markers have means 0 and standard deviations 1 since we can always standardize the
markers using the control distribution. We write
(
X
Y
)
∼ BVN
((
0
0
)
,
(
1 ρ
ρ 1
))
in controls
and (
X
Y
)
∼ BVN
((
µX
µY
)
,
(
1 ρ
ρ 1
))
in cases.
3
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The ROC curve for X alone is binormal with intercept µX and slope 1
ROCX(f) = Φ{µX + Φ−1(f)}
because X ∼ N(0, 1) in controls and X ∼ N(µX , 1) in cases (Pepe, 2003). The AUC for X
is
AUCX = Φ(µX/
√
2).
With µX = 0.742, we have AUCX = 0.7 and ROCX(0.05) = 0.183, implying that using a threshold
that corresponds to FPR = 5%, the test detects 18.3% of the cases. This reflects the approximate
performance of CA-125 for detecting ovarian cancer 2 years before clinical symptoms.
The ROC curve and AUC for Y alone take the same forms as those forX , but with µY replacing
µX . Values of µY in the range 0 to 0.742 were considered as they correspond to performance
ranging between that of a useless marker (AUC = 0.5; ROC(0.05) = 0.05) and that of the standard
marker X (AUC = 0.7; ROC(0.05) = 0.183).
For the bivariate binormal model with equal correlation, it is well known that
r(X, Y ) = expit(α0 + α1X + α2Y )
where α1 = (µX−ρµY )/(1−ρ2), α2 = (µY−ρµX)/(1−ρ2), and expit(W ) = exp(W )/{1+exp(W )}.
The combination of X and Y with optimal ROC curve is therefore W = α1X + α2Y , noting that
the ROC curve for expit(W ) is the same as that for W because expit is a monotone increasing
function. Since a linear combination of normal variables is normally distributed, it follows that the
best combination has a binormal ROC curve
ROCX,Y (f) = Φ
 µX +
α2
α1
µY√
1 +
α22
α21
+ 2α2ρ
α1
+ Φ−1(f)

and
AUCX,Y (f) = Φ

µX +
α2
α1
µY√
2
(
1 +
α22
α21
+ 2α2ρ
α1
)
 .
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When ρ = 0, the expressions simplify to
ROCX,Y (f) = Φ
{√
µX2 + µY 2 + Φ
−1(f)
}
and
AUCX,Y = Φ
(√
µX2 + µY 2
2
)
.
Therefore, when ρ = 0, larger values of µY lead to higher ROC values for the combination. In
other words, if a marker is uncorrelated with X , its marginal performance determines the perfor-
mance of the combination — markers that perform better on their own lead to better performing
combinations. This is not surprising. However, the magnitude of improvement in performance
is surprisingly small (Figure 1(a)). Fixing the FPR at 0.05, we see that when the AUC for Y is
0.6, only 2.3% more cases are detected, i.e. ROCX,Y (0.05) = 0.206 versus ROCX(0.05) = 0.183.
When Y on its own performs as well as X , (AUCY = 0.7), only 9.3% more cases are detected,
i.e. ROCX,Y (0.05) = 0.276 versus ROCX(0.05) = 0.183. For AUCY = 0.6, Figure 2(a) left panel
illustrates marker values classified as positive or negative using the optimal rule. See Supple-
mentary Figure S1 for plots analogous to those in Figure 1, pertaining to AUCX,Y rather than
ROCX,Y (0.05) as the measure of combination performance, though we consider AUCX,Y less clin-
ically relevant.
Figure 1(b) concerns markers that may be correlated with X , ρ > 0. Interestingly, a positive
correlation leads to a U-shaped curve for performance of the combination as a function of the
marginal performance of Y (left panel). The inflection point occurs at AUCY = Φ(ρµX/
√
2), i.e.
µY = ρµX , where the coefficient α2 for Y is equal to 0 and the optimal combination is determined
to be X alone. From the right panel of Figure 1(b), we see that for markers with performance as
good asX , i.e. AUCY = 0.7, performance improvement is maximized when ρ = 0 and decreases to
no improvement when ρ = 1. In the latter setting, Y provides the same information asX so it adds
nothing over X alone. Interestingly, however, for markers that are poor performers on their own
(AUCY < 0.7), the existence of a correlation with X in cases and in controls yields a combination
with improved performance. In the extreme, when AUCY = 0.5 and ρ = 1, the combination is a
5
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Figure 1: Bivariate Binormal Markers - Detection of cases by the combination (X ,Y ) at the thresh-
old that leads to FPR = 0.05. The baseline markerX alone detects 18% of cases (AUCX = 0.7) and
is indicated by a black dashed line. Shown are settings where (a) the correlation between markers
in both cases and controls is 0, (b) the correlation is equal in cases and controls with positive coef-
ficient ρ, and (c) the markers have a different correlation in controls and in cases, with correlation
coefficients ρD¯ and ρD, respectively. See Supplementary Figure S1 for analogous plots pertaining
to AUCX,Y as the measure of combination performance.6
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(a) Equal Correlation
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(b) Unequal Correlation (ρD¯ = 0)
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Figure 2: Decision boundaries that separate positive and negative classifications based on (X ,Y )
when ROCY (0.05) = 0.100 (or equivalently when AUCX,Y = 0.6 for (a) and (b)). The FPR = 0.05
and FPR = 0.10 boundaries are shown with solid and dashed curves, respectively. Both the opti-
mal and linear boundaries are shown. The solid points represent cases, while the hollow circles
represent controls. Shown are settings where (a) the correlation between markers is equal in cases
and controls, (b) the markers have a different correlation in controls and in cases, with correlation
coefficients ρD¯ (set to 0) and ρD, respectively, and (c) the markers have a mixture bivariate binor-
mal distribution in cases, with X and Y being discriminatory in proportions pX and pY of cases,
respectively. We set pY = 0.4 and pX = 0.15, 0.4. See Supplementary Figure S2 for more examples.
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perfect marker. The classification of marker values as positive or negative when AUCY = 0.6 and
ρ = 0.7 is shown in Figure 2(a) right panel.
The fact that poorly performing but highly correlated markers can add substantially to marker
performance is an intriguing observation that we found surprising initially. However, such phenom-
ena can arise in several practical settings. Consider that a measurement X made from a biological
sample may be comprised of two biologic components, X = W+Y . If the component W is an
excellent marker that cannot be measured and Y is a component that is unrelated to disease, then
Y is a useless marker on its own, but in combination with X it yields W , the excellent marker.
For example, the biomarker prostate-specific antigen (PSA) is made up of free and bound PSA
components. As another example, consider the setting where Y is a baseline measurement of a
biomarker, X is the current value and W is the change in the marker from baseline to present. If
the change in the marker is strongly associated with occurrence of disease, the current measure X
along with a possibly uninformative baseline value Y yields the change,W , which is an excellent
marker. As examples, it has been hypothesized that the change in CA-125 and in PSA may be
more informative of ovarian cancer and prostate cancer, respectively, than values measured at one
point in time (Berger et al., 2005; McIntosh, Urban, and Karlan, 2002; Skates et al., 1995; Skates
and Pauler, 2001; Slate and Cronin, 1997).
2.2.2 Bivariate Binormal Unequal Correlation Markers
Two markers may have a different correlation in cases than in controls. For example, there may be
a high correlation in cases but a low correlation in controls. This would occur if both markers are
at higher levels in cases with more extensive disease and at lower levels in cases with less extensive
disease, a likely scenario for many markers. Markers of cell growth and inflammation fit this sort
of scenario. For this setting we consider the following general joint model:(
X
Y
)
∼ BVN
((
0
0
)
,
(
1 ρD¯
ρD¯ 1
))
in controls
and (
X
Y
)
∼ BVN
((
0
0
)
,
(
1 ρD
ρD 1
))
in cases,
8
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where subscripts D¯ and D are used for controls and for cases, respectively. The optimal marker
combination is no longer linear when ρD 6= ρD¯. The risk function r(X, Y ) can be shown to be a
monotone function of ( 1
1−ρ2D
− 1
1−ρ2
D¯
)X2 + ( 1
1−ρ2D
− 1
1−ρ2
D¯
)Y 2 − 2( ρD
1−ρ2D
− ρD¯
1−ρ2
D¯
)XY +
1
1−ρ2D
{−2(µX − ρDµY )X − 2(µY − ρDµX)Y + (µ2X + µ2Y − 2ρDµXµY )}.
Figure 2(b) shows marker values classified as positive and negative using this non-linear opti-
mal combination for different values of ρD, assuming ρD¯ = 0. We see that discordance of marker
values leads to negative classification while concordance leads to positive classification for disease.
That is, if one marker is high but is not confirmed by a high value for the other marker, the subject
is unlikely to be classified as a case. The result makes sense intuitively for this model.
Figure 1(c) shows the increment in performance gained by combining Y with X when the
correlation is unequal between cases and controls. These calculations were made using large sim-
ulations since an analytic formula for ROCX,Y (f) was not feasible in this setting. In the left panel
corresponding to the special setting where ρD¯ = 0 and ρD > 0, we see that better marginal per-
formance of Y always leads to better performance for the combination (X, Y ) and that stronger
correlation of the markers in cases leads to better performance. Much larger gains in performance
are possible when Y is correlated withX in cases (ρD > 0) compared with when ρD = 0, the setting
shown in Figure 1(a). For example, if AUCY = 0.7 and it is uncorrelated with X in cases (Fig-
ure 1(a)), the combination can detect only 9.3% more cases than X alone (ROCX,Y (0.05) = 0.276
versus ROCX(0.05) = 0.183). However, from the left panel of Figure 1(c) we see that it can detect
17% more cases (ROCX,Y (0.05) = 0.349) when ρD = 0.6 and 22% (ROCX,Y (0.05) = 0.400) when
ρD = 0.8. Moreover, observe that even when Y is not useful on its own (AUCY = 0.5), it can greatly
improve the performance of X if it is correlated with X only in cases.
When markers have a positive correlation in controls, we see from the right two panels of
Figure 1(c) that the performance of (X, Y ) combined is a U-shaped function of ρD. Better per-
formance occurs when ρD and ρD¯ are very different. This also leads to the somewhat unintuitive
result that when markers are highly correlated in controls, ρD¯ = 0.9, worse marginal performance
of Y leads to better performance of the combination.
9
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Figure 3: Bivariate Binormal Unequal Correlation Markers - Comparison of decision rules in
detecting cases when FPR = 0.05. Shown here are (X ,Y ) combinations using the optimal risk
score, a logistic model with linear terms and a logistic model with linear and interaction terms. The
baseline marker X alone detects 18% of cases and is indicated by a black dashed line. Markers
have 0 correlation in controls and correlation ρD in cases.
We noted earlier that the optimal marker combination is non-linear when marker correlations in
cases and controls are unequal (Figure 2(b)). However, it is common practice to use the coefficients
from a linear logistic model to obtain a combination of the form αˆ1X + αˆ2Y . Figure 2(b) shows
marker values classified as positive and negative at FPR = 0.05 and FPR = 0.10, using such linear
combinations derived from the logistic likelihood. We see that the structure imposed by unequal
correlation in cases and controls implies that linear decision boundaries do not approximate very
well the non-linear optimal boundaries. Figure 3 compares the combinations with respect to TPR
when FPR is set equal to 0.05. We see from the right two panels that the linear combination has
performance comparable with the optimal combination for AUCY ≥ 0.6 when ρD < 0.5, but with
ρD > 0.5 it has relatively poor discriminatory ability. Interestingly, when AUCY = 0.5, the linear
combination performs even worse than X alone. We also find that when an interaction term is
added to the model, performance is often improved significantly, but is not comparable with the
optimal combination when correlation betweenX and Y is high in cases but zero in controls.
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2.2.3 Mixture Bivariate Binormal Markers
Diseases are often heterogeneous in nature. This is particularly true for cancer where it is thought
that unknown subtypes exist. Correspondingly, different biomarkers may be associated with dif-
ferent subtypes. The following statistical model incorporates this concept:(
X
Y
)
∼ BVN
((
0
0
)
,
(
1 0
0 1
))
in controls
and (
X
Y
)
∼ pXBVN
((
µX
0
)
,
(
1 0
0 1
))
+ pYBVN
((
0
µY
)
,
(
1 0
0 1
))
+(1− pX − pY )BVN
((
0
0
)
,
(
1 0
0 1
))
in cases.
That is, in cases the distribution for (X, Y ) is a mixture of three distibutions. An interpretation
is that X is discriminatory in a proportion pX of cases, while Y is discriminatory in a different
proportion pY of cases. The ROC curves for X and Y alone are mixture binormal. In particular,
for X we have:
ROCX(f) = pXΦ{µX + Φ−1(f)}+ (1− pX)f
with corresponding AUC:
AUCX = pXΦ(µX/
√
2) + (1− pX)/2.
The ROC and AUC for Y take the same forms, but with µY replacing µX and pY replacing pX . Ob-
serve that there are two parameters that define the marginal performance of each marker, (pX , µX)
forX and (pY , µY ) for Y . We set the performance ofX as before, such that ROCX(0.05) = 0.183,
which is achieved under two configurations that we consider here, (pX , µX) = (0.15, 3.17) and
(pX , µX) = (0.4, 1.35). The marginal performance of Y ranges from useless, ROCY (0.05) = 0.05,
to that of X , ROCY (0.05) = 0.183. By fixing pY = 0.15 this corresponds to µY ranging from 0 to
3.17 while setting pY = 0.4 this corresponds to µY ranging from 0 to 1.35. Note that for a fixed
overall performance criterion, smaller values for the proportion of marker-specific cases, p, corre-
spond to larger values of µ, which in turn correspond to better detection of those marker-specific
11
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cases. Moreover, note that the proportion of marker-specific cases imposes a bound on the maxi-
mum performance that can achieved by that marker. For example, when pY = 0.15, the maximum
ROCY (0.05) is 0.193, no matter how large µY may be. Intuitively, this makes sense in the given
context of heterogeneous diseases, where a marker may have good discriminatory ability within
a particular subtype, but if that subtype occurs very rarely the marker may not prove to be very
useful in the overall classification of subjects as positive or negative for the disease.
Figure 4 shows the increment in performance gained by combining Y withX . Again, these cal-
culations were made using large simulations since deriving an analytic formula for ROCX,Y (f)was
not feasible. Gains in performance are small when Y is comparable withX (ROCY (0.05) = 0.183),
about 10% when pX = 0.15 and 8% when pX = 0.4 (Figure 4(a)). The gains are miniscule when
ROCY (0.05) = 0.100. It is interesting that for ROCY (0.05) = 0.183, we see a somewhat larger
performance increment when pX = 0.15 (ROCX,Y (0.05) = 0.274 at pY = 0.25), compared to when
pX = 0.4 (ROCX,Y (0.05) = 0.249 at pY = 0.25). Moreover, while ROCX,Y (0.05) generally stays
constant over varying pY , there is a slight upward spike observed for pY < 0.2. This result is
noteworthy since it implies that for a fixed marginal performance, markers with lower subtype
prevalence are to be preferred. That is, the larger separation of marker values between marker-
specific cases and controls for pY = 0.15 makes a joint classification rule that is more effective.
This idea is illustrated in Figure 4(b), where a larger increment occurs for pY = 0.15 than for
pY = 0.4. An analogous result holds for pX and we see that the largest increment of 10% occurs for
the setting where both subtypes have lower prevalence but have markers that are highly sensitive.
Nevertheless we see that the increment in performance is fairly small in all settings for the mixture
bivariate binormal setting.
As shown in Figure 2(c), the optimal marker combination in the mixture bivariate binormal
setting is again non-linear. The risk function, r(X,Y), is a monotone function of
pXexp(−µ2X/2 + µXX) + pY exp(−µ2Y /2 + µY Y )
In Figure 2(c), we use this optimal combination as well as a linear combination based on a logistic
model to classify marker values as positive or negative at FPR = 0.05 and FPR = 0.10. While the
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Figure 4: Mixture Binormal Markers - Detection of cases by the combination (X ,Y ) and the
threshold that leads to FPR = 0.05. The performance ofX alone is indicated by a black dashed line
that remains constant at ROCX(0.05) = 0.183. Shown here are results for when (a) ROCY (0.05)
is fixed and the combination performance is observed over pY varying from 0.15 to 1 - pX and
(b) pY is fixed and ROCY (0.05) is varied from 0 to 0.183.
flexibility of the optimal rule fits the structure of the data better, a linear boundary can perform rel-
atively well here (also see Supplementary Figure S3). When pX = 0.15 and ROCY (0.05) = 18.3%,
ROCX,Y (0.05) = 29% using the optimal rule versus ROCX,Y (0.05) = 24% using the linear rule.
The linear rule gains about half the increment gained by the optimal rule across all values of pY .
When pX = 0.4 and ROCY (0.05) = 18.3%, ROCX,Y (0.05) = 27% using the optimal rule versus
ROCX,Y (0.05) = 23% using the linear rule in the scenario where pY = 0.15. As pY increases, the
performance of the linear rule closely approximates that of the optimal rule.
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2.3 General Implications of Numerical Studies
In the above numerical studies we investigated the incremental value of Y under three specific
scenarios for the joint behaviors of X and Y . We found that under the mixture bivariate binormal
model and the classic bivariate binormal model with equal variances in cases and controls and zero
correlation, the increment in performance is typically very small. This holds true even when Y ’s
performance is comparable with that of X . We found much larger gains in performance under
alternative bivariate binormal scenarios including: novel markers with poor marginal performance
but highly correlated withX conditional on disease status; and novel markers uncorrelated withX
in controls but highly correlated with X in cases (and vice versa).
Our simulations covered a very limited set of scenarios. In practice, markers may not follow the
mixture model or the binormal model or they may have different variances in cases versus controls
for example. Therefore, our results do not provide specific guidance on which markers are likely to
yield substantial improvements in performance in practice. Rather they suggest casting a wide net
in the search for novel markers. Restricting the search for novel markers to those that have good
marginal performance or low correlation, as is common practice, is ill advised. We also showed
that combining markers with linear rules may be too restrictive. Much better combinations than
linear combinations existed in several of the scenarios we studied.
3 Comparing Broad and Standard Strategies for SelectingMarker
Panels
We now turn to strategies for using data to select a small subset of markers from a large set of
markers for further study with the goal of developing a marker combination with good classifi-
cation performance. The standard approach is to rank markers according to their marginal clas-
sification performance, to select the top K ranking markers, and to evaluate all combinations of
those K markers. The results of our numerical studies suggest that this approach may miss mark-
ers that perform extremely well in combination. Therefore we investigate here a broader selection
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strategy that evaluates combinations of all available markers regardless of marginal marker per-
formance. To keep the problem simple and hopefully more insightful, we consider only pairwise
combinations as above.
3.1 Colon Cancer Dataset
Autoantibodies to tumor antigens may be useful for cancer screening. We use a dataset comprised
of 2100 protein microarray autoantibody measurements from 70 case subjects with colon cancer
and 70 control subjects. We transformed each marker so that its distribution in controls was normal
with mean 0 and standard deviation 1. We used a random set of 100 of the 2100 markers measured
on a random subset of 70 subjects. The standard and broad strategies were applied. These 70
subjects were used as the training dataset to select the top P = 10 marker combinations under both
strategies. We reserved the data on the remaining 70 subjects to act as a test dataset for performance
evaluation.
In the standard strategy, all pairwise combinations of the K = 10 markers with best marginal
performances were considered. Pairs were combined using logistic regression and their AUCs es-
timated with cross validation. The P = 10 combinations with highest cross-validated AUCs were
then evaluated on the independent test dataset in order to determine the performance of combi-
nations derived from the standard strategy. In the broad strategy, logistic regression was applied
to all pairs regardless of their marginal performance and the P = 10 combinations with highest
cross-validated AUCs were evaluated in the test dataset. We used logistic regression with interac-
tion terms in one analysis and logistic regression without interaction terms in another in order to
determine if a more complex model yielded better combinations.
Results for a single dataset (see Supplementary Table S1) show that the broad strategy yields
worse combinations than the standard strategy in this setting. However, no general conclusions can
be drawn from results of one dataset as we found substantial variation in results with the split of the
dataset into training and test components and with the random sample of 100 markers included.
Therefore we repeated this exercise 100 times and summarized the results in Figure 5(a). Each
15
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Table 1: Proportion of repetitions in which the kth ranking combination in the training dataset had
a higher test dataset AUC from the first strategy than from the second strategy.
(a) Original Colon Cancer Dataset (N = 140)
Marker Broad, no interaction > Broad, w/ interaction > Broad, w/ interaction >
Rank Standard, no interaction Standard, w/ interaction Broad, no interaction
1 0.22 0.28 0.44
2 0.29 0.21 0.38
3 0.29 0.32 0.38
4 0.33 0.26 0.35
5 0.32 0.31 0.35
6 0.35 0.24 0.37
7 0.27 0.24 0.37
8 0.32 0.26 0.35
9 0.28 0.26 0.45
10 0.36 0.26 0.37
(b) Expanded Colon Cancer Dataset (N = 7,000)
Marker Broad, no interaction > Broad, w/ interaction > Broad, w/ interaction >
Rank Standard, no interaction Standard, w/ interaction Broad, no interaction
1 0.89 0.95 0.74
2 0.95 0.98 0.75
3 0.89 0.91 0.67
4 0.89 0.98 0.74
5 0.96 0.96 0.73
6 0.90 0.92 0.77
7 0.89 0.91 0.74
8 0.89 0.94 0.69
9 0.84 0.90 0.71
10 0.93 0.94 0.71
16
http://biostats.bepress.com/uwbiostat/paper378
(a) Original Colon Cancer Dataset (N = 70 in the training dataset)
(b) Expanded Colon Cancer Dataset (N = 3,500 in the training dataset)
Figure 5: Comparison of standard and broad strategies, using 100 repetitions of different sets of
100 markers and training-test data from the (a) original and (b) expanded colon cancer datasets.
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boxplot contains 1000 AUC values, showing distributions of the AUCs estimated with the test
dataset for the top 10 marker combinations derived from the training dataset. Table 1(a) shows
the proportion of repetitions in which the kth ranking combination derived from the broad strategy
in the training dataset had a higher test dataset AUC than that for the kth ranking combination
derived from the standard strategy. We see that in general the broad strategy yields worse marker
combinations than the standard strategy, not better combinations as we had hoped. Use of more
complex combinations that include an interaction term led to even poorer performance. These
disappointing results however were reversed when we repeated the exercise in a larger dataset.
Since we did not have access to a large real dataset, we expanded the colon cancer dataset by a
factor of 50 by replicating it and adding to each biomarker value normally distributed noise with
mean 0 and standard deviation 0.01. Results shown in Figure 5(b) and Table 1(b) show that in
this much larger dataset, the broad strategy finds better performing marker combinations than does
the standard strategy. For example, the top marker pair derived with the broad strategy had better
performance than the top marker pair derived with the standard strategy in 95% of the repetitions
when a logistic model with interaction was used for combining markers. Moreover, including an
interaction term in the logistic model was beneficial in this dataset. We see that using the broad
strategy, the top marker combination derived from the model including an interaction had AUC
higher than the top marker combination derived from the model without interaction in 74% of the
repetitions.
4 Discussion
Results from the colon cancer dataset suggest that a broad search strategy can be useful in iden-
tifying markers for combination. More dramatic results were observed with simulated datasets
where markers with joint distributions discussed earlier in this paper were included among can-
didate markers available (See Appendix A). Those results also showed advantages for including
interaction terms in the combination score. Advantages of the broad search and flexible score
are however only realized when large datasets are available for identifying the combinations. In
18
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current practice, datasets for identifying markers are usually small. We propose that much larger
sample sizes be used for these studies in the future.
How should one choose the sample size of a marker panel identification study? One approach
is to perform simulation studies based on hypothesized joint distributions for biomarkers. By
varying the size of the simulated dataset one can determine the sample size at which good marker
combinations are likely to rank highly and are therefore likely to be pursued in further studies.
If pilot data are available one could base simulation studies on that. For example, suppose the
colon cancer dataset were pilot data and we were to design another panel identification study,
we could expand the pilot dataset as we did earlier, and determine at what expanded size the
selected combination or combinations are highly likely to have performance that is at or above
some target.
Note that in practice combining markers does not always lead to improvements in performance.
In particular, non-optimal combinations may have worse performance than either marker on its
own. We saw this in the left panel of Figure 3. A simple example involving the equal correla-
tion bivariate binormal model is reported in Appendix B. One must be cognizant that sampling
variability in coefficient estimates for risk models is one factor that leads to suboptimal marker
combinations.
In summary, we have shown that the practice of restricting attention to markers with good
marginal performance has the potential to miss certain marker combinations that perform ex-
tremely well. Although we investigated combinations of only two markers, the implication is
clearly true for combinations of more than two markers as well. We showed that by broadening the
strategy for assembling marker panels to include markers with poorer marginal performance that
appear to contribute substantially to combination performance, better marker combinations may be
found. However, large sample sizes will be required for these marker panel identification studies
in order for the broadened strategy to be fruitful.
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Appendix A: Simulated Dataset
We evaluated our methods on data simulated from the models presented in Sections 2.2.1 and 2.2.2.
To do so, we generated 50 pairs of baseline and novel markers that had joint bivariate binormal
distributions with equal and unequal correlations in cases and controls, varying from 0 to 0.9. In
each pair, the baseline marker was set to have AUC = 0.7, while the marginal performance of the
second marker ranged from AUC = 0.5 to AUC = 0.7 (specifically, AUC = 0.5, 0.55, 0.6, 0.65,
0.7). Using all five of these AUC values and ρ = 0, 0.5, 0.95, we generated 15 pairs from the equal
correlation model. Using the same five AUC values for the second marker, we also generated
data from the unequal correlation model: five pairs with ρD¯ = 0 and ρD = 0.7 and 30 pairs using
all six combinations of ρD¯ = (0.1, 0.5, 0.95) and ρD = (0.1, 0.5, 0.95), where ρD¯ 6= ρD. Along
with 10 additional markers that were normally distributed noise (mean 0 and standard deviation 1)
independent of all other markers, a total set of 110 markers was generated.
A fairly small training dataset of 250 case subjects and 250 control subjects (N = 500) was
created in order to illustrate and compare the standard restrictive approach to selecting markers for
combination with a broader strategy. To investigate the effect of using a larger dataset for marker
combination selection, we repeated the analysis with a dataset of 500 case subjects and 500 control
subjects (N = 1000). In both cases, we calculated the performance of selected combinations using
Monte Carlo calculations with a very large simulated dataset. We used the area under the ROC
curve here to quantify discrimination since it has less variability in small samples than estimated
points on the ROC curve.
As discussed in the text for the colon cancer dataset, in the standard strategy, all pairwise com-
binations of the K = 10 markers with best marginal performances in the training dataset were
considered. Pairs were combined using logistic regression in the training dataset and their AUCs
estimated with cross validation. The P = 10 combinations with highest cross-validated AUCs in
the training dataset were then evaluated on the independent large dataset in order to determine the
performance of combinations derived from the standard strategy. In the broad strategy, logistic re-
gression was applied to all pairs in the training dataset regardless of their marginal performance and
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the P = 10 combinations with highest cross-validated AUCs were evaluated on the large dataset.
We used logistic regression with interaction terms in one analysis and logistic regression without
interaction terms in another in order to determine if a more complex model yielded better combi-
nations.
Results for a single dataset are shown in Table A1. We focus first on the smaller dataset of 500
subjects. For both logistic models, all of the top combinations selected by the standard strategy in-
volve pairs of markers that have good marginal performance (AUC = 0.7) and that are uncorrelated
with each other in cases and in controls. These combinations have AUC values ranging from 0.768
to 0.771 — a moderate improvement over the baseline AUC of 0.7. The standard strategy misses
three better combinations that are selected by the broad strategy with AUC values ranging from
0.817 to 0.944. These are marker pairs that are highly correlated in cases and controls (ρ = 0.95)
and where the second markers perform poorly on their own (AUC = 0.5, 0.55, 0.6). Note that all
of the combinations selected using this smaller dataset (by both strategies and using both logistic
models) only involve marker pairs that have equal correlation in cases and controls and therefore
have optimal combinations that involve only linear terms.
Because the simulation model is known, we know the optimal marker combinations. The AUCs
of the 10 optimal combinations are also listed in Table A1. The top two combinations come from
equal correlation marker pairs with a poorly-performing second marker, and are in fact the same
as the two best marker pairs selected by the broad strategy using the smaller dataset (N = 500).
However, the combination derived from the dataset is suboptimal because of sampling variability
in the logistic regression coefficient estimates. The rest of the optimal marker combinations cor-
respond to marker pairs with unequal correlation in cases (ρD = 0.95) and controls (ρD¯ = 0.1) and
varying marginal performance of the second marker (AUC = 0.5 to AUC = 0.7). These pairs have
non-linear optimal combinations, and therefore one may expect some of them to be selected using
the logistic model with interactions. However, it seems that the dataset is too small to correctly fit
the more complicated model and to select combinations based on it. This problem was amplified
when we investigated a third logistic model including quadratic terms. Using a sample size of 500,
it performed poorly compared to the two simpler models (data not shown).
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For each model, we also explore asymptotic behavior using a large dataset (N = 100,000) for the
selection of top combinations. For the same marker pairs, the large dataset tends to produce better
estimates of the logistic regression coefficients and therefore combinations with slightly higher
AUC values than those from a dataset of size N = 500. It is not surprising then, that when we
increase the size of our training dataset to N = 1000, we see an increase in AUC values compared
to when N = 500. Using the logistic model with interaction, the broad strategy is now able to
select a marker pair with unequal correlation in cases (ρD = 0.95) and controls (ρD¯ = 0.1), where
the optimal combination includes an interaction term. The AUC based on N = 1000 is 0.787.
The corresponding large sample asymptotic AUC is 0.802, much smaller than the optimal AUC of
0.898. This inconsistency between the asymptotic AUC and the optimal AUC is no surprise given
the theoretical results we saw earlier. Recall Figure 3, where we illustrated that a logistic model
with an interaction term alone does not estimate the optimal combination well for high ρD when
ρD¯ = 0.
Results from 100 datasets are summarized in Figure A1, where for the standard and broad
strategies, we show distributions of AUCs calculated using a large dataset for the top 10 marker
combinations derived from the smaller datasets. In all, 1000 AUC values enter into the ‘Standard’
and ‘Broad’ box plots, 10 from each of the 100 repetitions. The boxplots labeled ‘Large Sample’
and ‘Optimal’ each contain AUC values for 10 marker combinations selected as described above,
using a very large sample and the optimal risk score, respectively.
These results are consistent with the single dataset results. The broad strategy tends to select
marker combinations that are at least as good as those selected by the standard strategy and both
strategies perform slightly better when using a larger dataset (N = 1000 versus N = 500). The top
combinations selected by the broad strategy tend to be of marker pairs that are highly and equally
correlated in cases and controls with a second marker that has low marginal performance. The
optimal combination in this case is linear and the simpler logistic model and smaller sample size
(N = 500) seem to be adequate for selecting these combinations.
Based on the results for N = 1000, there appears to be little advantage of using a more complex
24
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model over a model with linear terms only. The large sample performance, however, shows some
improvement in AUCs with the more complicated model. This finding indicates that N = 1000
might not be large enough to reap the full benefits of including an interaction term. Moreover,
as mentioned above, a model that includes only an interaction term is limited in how closely it
approximates the optimal combination of markers with unequal correlation in cases and controls.
Using an even larger sample size with quadratic terms would be expected to generate a larger
increment in combination performance.
25
Hosted by The Berkeley Electronic Press
(a) N = 500 in the training dataset
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(b) N = 1000 in the training dataset
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Figure A1: Results of 100 repetitions with 110 markers simulated based on the joint distributions
presented in Sections 2.2.1 and 2.2.2. For logistic models with and without an interaction term,
top ranking marker combinations were selected using the standard and broad strategies in training
datasets of sizes (a) N = 500 and (b) N = 1000. For these combinations, AUC values calculated
from a large dataset are presented here. The asymptotic behavior under each model is denoted by
‘Large Sample’ and shows top ranking combinations selected using a dataset of size N = 100,000.
Also presented are top ranking combinations obtained using optimal risk scores. Marker combina-
tions are different in different boxplots.
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Appendix B: Combinations Gone Wrong
For the bivariate binormal equal correlation scenario, we showed in Section 2.2.1 that the optimal
combination of X and Y is X + γY , where γ = α2
α1
= µY −ρµX
µX−ρµY . Using this value of γ always
improves performance relative to X alone. However, in practice we generally do not know this
optimal γ. One must be cautious when combining markers, as non-optimal values of γ can yield
combinations with worse performance than X alone, as shown in Figure B1 below.
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Figure B1: Bivariate Binormal Equal Correlation Markers - Detection of cases by the combina-
tion X + γY , using the threshold that leads to FPR = 0.05. The peaks in these plots denote
the optimal combination performance, observed when γ = α2
α1
. The performance of X alone
(ROCX(0.05) = 0.183) is indicated by a black dashed line.
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(c) Unequal Correlation
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Figure S1: Bivariate BinormalMarkers - Using AUCX,Y as a measure of classification performance
of the combination (X ,Y ). The baseline marker X alone has AUC = 0.7 and is indicated by a
black dashed line. Shown are settings where (a) the correlation between markers in both cases and
controls is 0, (b) the correlation is equal in cases and controls with positive coefficient ρ, and (c)
the markers have a different correlation in controls and in cases, with correlation coefficients ρD¯
and ρD, respectively.
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Figure S3: Mixture Binormal Markers - Comparison of decision rules in detecting cases when
FPR = 0.05. Shown here are (X ,Y ) combinations using the optimal risk score and a logistic
model with linear terms only, for varying values of pY and ROCY (0.05) when (a) pX = 0.15 and
(b) pX = 0.4. The baseline markerX alone detects 18% of cases and is indicated by a black dashed
line.
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Table S1: Results of data analysis for a single dataset derived from the original colon cancer dataset
by selecting 100 markers at random and a random split into training (N = 70) and test (N = 70)
datasets. Test dataset AUC values for top ranking marker combinations selected using the training
dataset are presented here. Marker combinations are different in different columns of the table.
Results within each column are sorted according to AUC.
Marker Linear Terms Linear + Interaction Terms
Combination Standard Broad Standard Broad
1 0.730 0.694 0.791 0.693
2 0.724 0.658 0.767 0.692
3 0.723 0.651 0.728 0.676
4 0.715 0.639 0.725 0.660
5 0.709 0.623 0.719 0.656
6 0.691 0.622 0.708 0.656
7 0.691 0.622 0.690 0.653
8 0.678 0.613 0.683 0.639
9 0.659 0.556 0.666 0.631
10 0.641 0.477 0.642 0.504
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